CAS: 174709-30-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 3H-Imidazo[4,5-g]quinazolin-8-amine, N-(3-bromophenyl)-3-methyl- REF: IN-DA001ZVWCAS: 174709-30-9 | - - - | To inquire | Thu 14 Nov 24 |
 | BPIQ-I REF: TM-T70227CAS: 174709-30-9 | - - - | 221.00 €~1,503.00 € | Thu 16 Jan 25 |
![3H-Imidazo[4,5-g]quinazolin-8-amine, N-(3-bromophenyl)-3-methyl-](https://static.cymitquimica.com/products/IN/thumb/DA001ZVW.jpg)
3H-Imidazo[4,5-g]quinazolin-8-amine, N-(3-bromophenyl)-3-methyl-
CAS:174709-30-9
Formula:
C16H12BrN5
Molecular weight:
354.2040
Ref: IN-DA001ZVW
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 14 Nov 2024
BPIQ-I
CAS:174709-30-9
BPIQ-I (PD 159121), an ATP-competitive EGFR tyrosine kinase inhibitor, exhibits potent anti-proliferative activity.
Formula:
C16H12BrN5
Color and Shape:
Solid
Molecular weight:
354.2
Ref: TM-T70227
| 1mg | 393.00 € | ||
| 5mg | 1,503.00 € | ||
| 500µg | 221.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
